T9789 |
Cevidoplenib dimesylate hydrochloride
|
269062-93-3
|
98%
|
|
Cevidoplenib dimesylate hydrochloride is a spleen tyrosine kinase (Syk) inhibitor showing potential immunomodulating and anti-inflammatory properties.
|
T4263 |
BAY 61-3606
|
732983-37-8
|
|
|
BAY 61-3606 (Syk inhibitor IV) is a potent, ATP-competitive, reversible, and highly selective inhibitor of Syk tyrosine kinase activity (Ki= 7.5 nM), exhibiting ...
|
T4391 |
Syk Inhibitor II dihydrochloride
|
227449-73-2
|
100%
|
|
Spleen tyrosine kinase (Syk) is a non-receptor tyrosine kinase that, upon phosphorylation, binds to immunoreceptor tyrosine-based activation motifs of FcRγ chain...
|
T39437 |
Cevidoplenib dimesylate
|
2043659-93-2
|
96.16%
|
|
Cevidoplenib dimesylate is an inhibitor of spleen tyrosine kinase (Syk), possessing anti-inflammatory and immunomodulating properties.
|
T16776 |
RO9021
|
1446790-62-0
|
97.19%
|
|
RO9021 is an orally bioavailable, novel ATP-competitive SYK inhibitor (average IC50: 5.6 nM).
|
T13045 |
Syk-IN-3
|
1312534-69-2
|
97.99%
|
|
Syk-IN-3 is a Syk inhibitor with potential anti-inflammatory and anticancer activity and can be used to study immune dysregulation.
|
T22430 |
SRX3207
|
2254693-15-5
|
98.14%
|
|
SRX3207 is an inhibitor of Syk and PI3K and relieves tumor immunosuppression.
|
T6115 |
Fostamatinib
|
901119-35-5
|
98.24%
|
|
Fostamatinib (R788)(IC50 of 41 nM), which is a prodrug of the active metabolite R406, is a Syk inhibitor. It does not work on Lyn.
|
T6594 |
MNS
|
1485-00-3
|
98.45%
|
|
MNS is a tyrosine kinases inhibitor, inhibits Syk, Src, p97 with IC50 of 2.5 μM, 29.3 μM and 1.7 μM, respectively.
|
T32088 |
Sovleplenib
|
1415792-84-5
|
98.51%
|
|
Sovleplenib (HMPL523) is an orally available, selective and potent inhibitor of the splenic tyrosine kinase SYK with an IC50 of 25 nM.Sovleplenib has antitumor a...
|
T6957 |
PRT-060318
|
1194961-19-7
|
98.82%
|
|
PRT-060318 (P142-76) is a novel selective inhibitor of the Syk tyrosine kinase, as an approach to HIT treatment.
|
T6174 |
R406
|
841290-81-1
|
98.82%
|
|
R406 (R-406 besylate) is an effective Syk inhibitor (IC50: 41 nM) and shows no effects on Lyn.
|
T6003 |
GSK1904529A
|
1089283-49-7
|
98.89%
|
|
GSK1904529A (GSK 4529) is a specific inhibitor of IGF-1R (IC50=27 nM) and IR(IC50=25 nM) .
|
T2605 |
Fostamatinib Disodium
|
1025687-58-4
|
98.95%
|
|
Fostamatinib Disodium (R788 Disodium) is an orally available Syk kinase inhibitor with potential anti-inflammatory and immunomodulating activities.
|
T3185 |
R112
|
575474-82-7
|
99.06%
|
|
R112 ((E)-Elafibranor) is an ATP-competitive inhibitor of Syk kinase.
|
T7035 |
ANTHRAQUINONE-2-CARBOXYLIC ACID
|
117-78-2
|
99.08%
|
|
Anthraquinone-2-carboxylic acid acts as a potent anti-inflammatory and antinociceptive component in vivo, thus contributing to the immune regulatory role of frui...
|
T6104 |
Cerdulatinib hydrochloride
|
1369761-01-2
|
99.23%
|
|
Cerdulatinib hydrochloride (PRT2070 hydrochloride) is an oral active, multi-targeted tyrosine kinase inhibitor with IC50 of 12 nM/6 nM/8 nM/0.5 nM and 32 nM for ...
|
T2467 |
R406 free base
|
841290-80-0
|
99.31%
|
|
R406 free base (R406 (free base)) is a potent Syk inhibitor.
|
T6057 |
URMC-099
|
1229582-33-5
|
99.32%
|
|
URMC-099 is an orally bioavailable, brain penetrant MLK inhibitor (IC50: 19/42/14/150 nM, for MLK1/MLK2/MLK3/DLK), and also inhibits LRRK2 activity (IC50: 11 nM)...
|
T0610 |
Piceatannol
|
10083-24-6
|
99.39%
|
|
Piceatannol (Astringenin) is an anti-inflammatory, immunomodulatory and antiproliferative agent. It inhibits p56lck and syk protein tyrosine kinases and inhibits...
|